vs
GE医疗（CCRN）与罗致恒富（RHI）财务数据对比。点击上方公司名可切换其他公司
罗致恒富的季度营收约是GE医疗的5.5倍（$1.3B vs $236.8M）。罗致恒富同比增速更快（-5.8% vs -23.6%）。罗致恒富自由现金流更多（$170.8M vs $16.1M）。过去两年罗致恒富的营收复合增速更高（-6.1% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
罗致恒富是1948年成立的国际人力资源咨询机构，总部位于加利福尼亚州门洛帕克和圣拉蒙，是全球规模领先的会计与金融领域人才派遣服务商之一，在全球范围内设有超过345个办公点。
CCRN vs RHI — 直观对比
营收规模更大
RHI
是对方的5.5倍
$236.8M
营收增速更快
RHI
高出17.8%
-23.6%
自由现金流更多
RHI
多$154.7M
$16.1M
两年增速更快
RHI
近两年复合增速
-21.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $1.3B |
| 净利润 | $-82.9M | — |
| 毛利率 | — | 37.6% |
| 营业利润率 | -30.2% | 1.7% |
| 净利率 | -35.0% | — |
| 营收同比 | -23.6% | -5.8% |
| 净利润同比 | -2109.7% | — |
| 每股收益（稀释后） | $-2.56 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNRHI
| Q4 25 | $236.8M | $1.3B | ||
| Q3 25 | $250.1M | $1.4B | ||
| Q2 25 | $274.1M | $1.4B | ||
| Q1 25 | $293.4M | $1.4B | ||
| Q4 24 | $309.9M | $1.4B | ||
| Q3 24 | $315.1M | $1.5B | ||
| Q2 24 | $339.8M | $1.5B | ||
| Q1 24 | $379.2M | $1.5B |
净利润CCRNRHI
| Q4 25 | $-82.9M | — | ||
| Q3 25 | $-4.8M | $42.9M | ||
| Q2 25 | $-6.7M | $41.0M | ||
| Q1 25 | $-490.0K | $17.4M | ||
| Q4 24 | $-3.8M | — | ||
| Q3 24 | $2.6M | $65.5M | ||
| Q2 24 | $-16.1M | $68.2M | ||
| Q1 24 | $2.7M | $63.7M |
毛利率CCRNRHI
| Q4 25 | — | 37.6% | ||
| Q3 25 | 20.4% | 37.2% | ||
| Q2 25 | 20.4% | 37.2% | ||
| Q1 25 | 20.0% | 36.9% | ||
| Q4 24 | — | 38.8% | ||
| Q3 24 | 20.4% | 39.0% | ||
| Q2 24 | 20.8% | 39.2% | ||
| Q1 24 | 20.4% | 38.1% |
营业利润率CCRNRHI
| Q4 25 | -30.2% | 1.7% | ||
| Q3 25 | -2.4% | 1.0% | ||
| Q2 25 | -2.1% | 0.1% | ||
| Q1 25 | -0.3% | 2.9% | ||
| Q4 24 | -1.1% | 4.7% | ||
| Q3 24 | 0.9% | 4.1% | ||
| Q2 24 | -5.7% | 5.1% | ||
| Q1 24 | 0.8% | 2.8% |
净利率CCRNRHI
| Q4 25 | -35.0% | — | ||
| Q3 25 | -1.9% | 3.2% | ||
| Q2 25 | -2.4% | 3.0% | ||
| Q1 25 | -0.2% | 1.3% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 0.8% | 4.5% | ||
| Q2 24 | -4.7% | 4.6% | ||
| Q1 24 | 0.7% | 4.3% |
每股收益（稀释后）CCRNRHI
| Q4 25 | $-2.56 | $0.32 | ||
| Q3 25 | $-0.15 | $0.43 | ||
| Q2 25 | $-0.20 | $0.41 | ||
| Q1 25 | $-0.02 | $0.17 | ||
| Q4 24 | $-0.13 | $0.53 | ||
| Q3 24 | $0.08 | $0.64 | ||
| Q2 24 | $-0.47 | $0.66 | ||
| Q1 24 | $0.08 | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $464.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $1.3B |
| 总资产 | $449.0M | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCRNRHI
| Q4 25 | $108.7M | $464.4M | ||
| Q3 25 | $99.1M | $365.3M | ||
| Q2 25 | $81.2M | $380.5M | ||
| Q1 25 | $80.7M | $342.5M | ||
| Q4 24 | $81.6M | $537.6M | ||
| Q3 24 | $64.0M | $570.5M | ||
| Q2 24 | $69.6M | $547.4M | ||
| Q1 24 | $5.2M | $540.9M |
股东权益CCRNRHI
| Q4 25 | $322.8M | $1.3B | ||
| Q3 25 | $408.1M | $1.3B | ||
| Q2 25 | $412.2M | $1.3B | ||
| Q1 25 | $418.2M | $1.3B | ||
| Q4 24 | $419.0M | $1.4B | ||
| Q3 24 | $424.7M | $1.5B | ||
| Q2 24 | $433.3M | $1.5B | ||
| Q1 24 | $462.4M | $1.5B |
总资产CCRNRHI
| Q4 25 | $449.0M | $2.9B | ||
| Q3 25 | $538.2M | $2.8B | ||
| Q2 25 | $553.8M | $2.8B | ||
| Q1 25 | $576.2M | $2.7B | ||
| Q4 24 | $589.3M | $2.9B | ||
| Q3 24 | $597.4M | $3.0B | ||
| Q2 24 | $602.9M | $2.9B | ||
| Q1 24 | $648.4M | $2.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $182.5M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $170.8M |
| 自由现金流率自由现金流/营收 | 6.8% | 13.1% |
| 资本支出强度资本支出/营收 | 0.9% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.1M | $266.8M |
8季度趋势，按日历期对齐
经营现金流CCRNRHI
| Q4 25 | $18.2M | $182.5M | ||
| Q3 25 | $20.1M | $77.4M | ||
| Q2 25 | $4.2M | $119.4M | ||
| Q1 25 | $5.7M | $-59.3M | ||
| Q4 24 | $24.2M | $154.8M | ||
| Q3 24 | $7.5M | $129.6M | ||
| Q2 24 | $82.4M | $142.0M | ||
| Q1 24 | $6.0M | $-15.9M |
自由现金流CCRNRHI
| Q4 25 | $16.1M | $170.8M | ||
| Q3 25 | $17.9M | $63.6M | ||
| Q2 25 | $2.3M | $104.2M | ||
| Q1 25 | $3.8M | $-71.7M | ||
| Q4 24 | $21.7M | $140.5M | ||
| Q3 24 | $6.3M | $111.8M | ||
| Q2 24 | $79.6M | $129.6M | ||
| Q1 24 | $3.8M | $-27.7M |
自由现金流率CCRNRHI
| Q4 25 | 6.8% | 13.1% | ||
| Q3 25 | 7.2% | 4.7% | ||
| Q2 25 | 0.8% | 7.6% | ||
| Q1 25 | 1.3% | -5.3% | ||
| Q4 24 | 7.0% | 10.2% | ||
| Q3 24 | 2.0% | 7.6% | ||
| Q2 24 | 23.4% | 8.8% | ||
| Q1 24 | 1.0% | -1.9% |
资本支出强度CCRNRHI
| Q4 25 | 0.9% | 0.9% | ||
| Q3 25 | 0.9% | 1.0% | ||
| Q2 25 | 0.7% | 1.1% | ||
| Q1 25 | 0.6% | 0.9% | ||
| Q4 24 | 0.8% | 1.0% | ||
| Q3 24 | 0.4% | 1.2% | ||
| Q2 24 | 0.8% | 0.8% | ||
| Q1 24 | 0.6% | 0.8% |
现金转化率CCRNRHI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | 2.91× | ||
| Q1 25 | — | -3.42× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | 1.98× | ||
| Q2 24 | — | 2.08× | ||
| Q1 24 | 2.23× | -0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
RHI
| Finance And Accounting | $535.2M | 41% |
| Protiviti | $479.0M | 37% |
| Technology | $156.4M | 12% |
| Permanent Placement Talent Solutions | $102.6M | 8% |
| Other | $29.2M | 2% |
